BIOLASE, Inc. (BIOL): Company Cash Volume

Official company branding of Biolase, Inc. (BIOL)

A stable staff of R&D experts ensures growth, as confirmed by the cash assets figure, where the current metric equals 0.01. The success of BIOLASE, Inc. (BIOL) is based on an impeccable reputation in laser dentistry. However, expansion relies on the openness of foreign markets, as trade barriers and electronic logistics disruptions could limit the inflow of liquidity into the company.

Company Cash Funds: Biolase Inc. (BIOL) for 07/04/2022 - 08/04/2024

Summary analytical data breakdowns for BIOLASE Inc. (BIOL)

- stock quotes and analyst forecast:
Initial company analysis:Biolase Inc. BIOL
Brand item of BIOLASE

This indicator determines the volume of liquid assets forming the company's financial buffer against market volatility. By analyzing the history of cash holdings, an investor assesses the balance between security and capital efficiency. The metric measures the business's ability to cover liabilities without incurring external debt. For BIOLASE, Inc. (BIOL), such reserves ensure stability while scaling the laser systems ecosystem. High margins on replacement tips create a steady cash flow, strengthening the issuer's fundamental resilience.

Analysis of competing companies

Company Cash Volume BSX|Company Cash Funds EW (Edwards Lifesciences Corporation)|Company Cash Funds ResMed RMD|Company Cash Volume Insulet Corp PODD|ZBH: Company Cash on Hand|Company Cash Balance COO (CooperVision)|ALGN (Align Technology, Inc.) - Company Cash on Hand|Globus Medical, Inc. - Company Cash Balance|TMDX (TransMedics Group Inc) - Company Cash Volume|Company Cash Reserve Alphatec Holdings ATEC|Company Cash Funds CryoLife (AORT)|Enovis Corporation (ENOV) - Company Cash Position|Integra LifeSciences Inc. - Company Cash on Hand|Company Cash Volume Establishment Labs ESTA|Beta Bionics, Inc. - Company Cash Volume|Company Liquid Assets IRADIMED Corp IRMD|Embecta (EMBC) - Company Cash Funds|Company Total Cash Volume TNDM (Tandem Corp)|Company Cash Funds axogeninc.com|Company Cash on Hand SI-BONE, Inc. (SIBN)|Company Cash Volume OFIX|Bioventus Corp - Company Cash and Cash Equivalents|Company Cash Funds orthopediatrics.com KIDS|TMCI: Company Cash and Cash Equivalents|SRTA: Company Cash on Hand|Carlsmed Inc - Company Total Cash Amount|RxSight (RXST) - Company Cash Funds|Company Cash on Hand ClearPoint|Company Cash on Hand STXS|Company Cash Reserve Neuronetics, Inc. STIM|Company Cash Volume SGHT|Company Cash on Hand Orchestra BioMed OBIO|Company Cash Funds Anika Therapeutics Inc. ANIK|NSPR (InspireMD) - Company Total Cash Volume|ZJYL - Company Cash Funds|VANI (vivani.com) - Company Cash and Cash Equivalents|XTNT (Xtant Medical Inc) - Company Cash on Hand|Company Cash Reserve n1mtc.com (NMTC)|Company Cash Funds modular-medical.com|Company Cash and Cash Equivalents MYO (Myomo)|Company Cash Volume COCH|VVOS (Vivos Therapeutics, Inc) - Company Cash Balance|Company Cash Funds envveno.com NVNO|SINT - Company Cash on Hand|Tenon Medical Inc. - Company Cash Volume|LFWD: Company Cash Funds|Autonomix (AMIX) - Company Cash Funds|IVF - Company Liquid Assets|BBLG (bonebiologics.com) - Company Cash Volume|Axonics, Inc. (AXNX) - Company Liquid Assets|Company Cash Volume DYNT|Company Liquid Assets Paragon 28|Company Cash Volume INVO (INVO Bioscience, Inc.)